Who we are
Many cannabinoids occur in only small amounts. But thanks to one of nature’s oldest processes, fermentation, we’ve pioneered a way to produce these cannabinoids at mass market scale.
These ingredients are ready to unleash a huge wave of product innovation across the beauty, skincare, food, beverage, health and wellness sectors. And now we’re ready to help customers like you bring the benefits of cannabinoids to every home, everywhere.
It’s game on. Are you ready to join in?
Do no harm
Any new innovation has to treat our world with respect. We have to find more sustainable ways of doing business.
That’s why we make our cannabinoid ingredients using one of the world’s oldest natural processes - fermentation.
Fermentation requires less water, energy and land than the plant-based approaches typically used to extract cannabinoid ingredients. This gives you, our customers, the ability to develop innovative new products without causing unnecessary harm to the planet.
And our ingredients are of the very highest quality, containing none of the contaminants often associated with plant-derived ingredients.
Do no harm
Any new innovation has to treat our world with respect. We have to find more sustainable ways of doing business.
That’s why we make our cannabinoid ingredients using one of the world’s oldest natural processes - fermentation.
Fermentation requires less water, energy and land than the plant-based approaches typically used to extract cannabinoid ingredients. This gives you, our customers, the ability to develop innovative new products without causing unnecessary harm to the planet.
And our ingredients are of the very highest quality, containing none of the contaminants often associated with plant-derived ingredients.
Meet the innovators
We walk the talk. Our leaders have decades of experience innovating at the intersection of technology, business and science.
Roy Lipski
Shuchi Sarkar
James Stephens
David Brinkmann
Dan Hawksley
Joel Cherry
Alastair James
Meet the innovators
We walk the talk. Our leaders have decades of experience innovating at the intersection of technology, business and science.
Joel Cherry
Roy Lipski
Shuchi Sarkar
James Stephens
David Brinkmann
Dan Hawksley
Alastair James
Meet the innovators
We walk the talk. Our leaders have decades of experience innovating at the intersection of technology, business and science.
Joel Cherry
Roy Lipski
Shuchi Sarkar
James Stephens
David Brinkmann
Dan Hawksley
Alastair James
An ecosystem of trust
Industry leader Genomatica is our joint venture partner, developing fermentation-based cannabinoid production technologies exclusively for us.
Genomatica has successfully commercialized fermentation-based processes to make available very large quantities of more sustainable ingredients used in everyday products ranging from plastics to personal care.
Our close relationship with Genomatica means you can be confident that we have the technology to deliver the reliable, high quality and consistent supply of the cannabinoid ingredients you need, at commercial scale.
An ecosystem of trust
Industry leader Genomatica is our joint venture partner, developing fermentation-based cannabinoid production technologies exclusively for us.
Genomatica has successfully commercialized fermentation-based processes to make available very large quantities of more sustainable ingredients used in everyday products ranging from plastics to personal care.
Our close relationship with Genomatica means you can be confident that we have the technology to deliver the reliable, high quality and consistent supply of the cannabinoid ingredients you need, at commercial scale.
Quality at scale
You need a consistent, reliable, high-quality supply of more sustainable ingredients that can scale with the needs of domestic or global markets.
We’ve built our supply chain to deliver exactly that:
Quality at scale
You need a consistent, reliable, high-quality supply of more sustainable ingredients that can scale with the needs of domestic or global markets. We’ve built our supply chain to deliver exactly that:
Home
We’ll help you create
innovative new products
We’re true partners with a proven
commercial record.
We’ll help you create
innovative new products
We’re true partners with a proven commercial record.
Creo’s founders have a history of successful innovation at scale.
The courage
to create
the future
Creo’s founders have a history of successful innovation at scale.
The courage to
create the future
Quality you can trust
By delivering pure cannabinoid ingredients in commercial quantities we’ll help you bring exciting new consumer products to the mass market.
A more sustainable source.
Available at scale.
High quality, consistent and free from contaminants.
Quality you can trust
By delivering pure cannabinoid ingredients in commercial quantities we’ll help you bring exciting new consumer products to the mass market.
A more sustainable source.
Available at scale.
High quality, consistent and free from contaminants.
Quality you can trust
By delivering pure cannabinoid ingredients in commercial quantities we’ll help you bring exciting new consumer products to the mass market.
A more sustainable source.
Available at scale.
High quality, consistent and free from contaminants.
CBG and CBGA
available at scale
CBG and CBGA
available at scale
CBG and CBGA offer enormous promise.
We’re enabling that promise to become reality.
CBG and CBGA
available at scale
CBG and CBGA offer enormous promise.
We’re enabling that promise to become reality.
A wide range of rare cannabinoids available now
You can now order a wide range of high-quality, rare cannabinoids
through our sourcing business, Curated by Creo.
Analyst firm Raymond James ranks Creo as one of the top players in the emerging cannabinoid biosynthesis market they estimate "growing from $10 bn in 2025 to $115 bn by 2040."
A wide range of rare cannabinoids available now
You can now order a wide range of high-quality, rare cannabinoids through our sourcing business, Curated by Creo.
Analyst firm Raymond James ranks Creo as one of the top players in the emerging cannabinoid biosynthesis market they estimate "growing from $10 bn in 2025 to $115 bn by 2040."
"Analyst firm Edison Research ranks Creo as one of the leadings players in the emerging cannabinoid biosynthesis market estimated to be worth some $30bn on an NPV basis.”